Clinical Trial Update: Q-Switched Nd:YAG in Macular Amyloidosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating Q-Switched Nd:YAG laser treatment for macular amyloidosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Amyloidosis

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Macular Amyloidosis | Phase 1 | Status: COMPLETED